Current strategies for prevention of oral manifestations of human immunodeficiency virus

Patton, Lauren L.

doi:10.1016/j.oooo.2015.09.004

Cited by 25 publications

(17 citation statements)

References 63 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…51,52,53 There is insufficient evidence to recommend intensive screening approaches, particularly since randomized trials have not been conducted to assess the efficacy of surgery in preventing cancer morbidity or mortality in any population. 54 However, a community-based trial of oral examinations in India, where incidence is high in the general population, reported a 24% reduction in oral cancer mortality among tobacco and alcohol users.…”

Section: Site-specific Screening Approachmentioning

confidence: 99%

Screening for Cancer in Persons Living with HIV Infection

et al. 2016

View full text Add to dashboard Cite

Survival with human immunodeficiency virus (HIV) infection has greatly improved due to effective antiretroviral therapy (ART). As infectious complications have declined, malignancy now accounts for over one-third of deaths among people living with HIV (PLWH). Based on practices in the general population, cancer screening of PLWH can decrease both morbidity and mortality. In this article, we review and consider directed approaches for colorectal, breast, cervical and lung cancer screening. Furthermore, routine physical examinations may detect lymphomas and skin, anal and oral cancers. Comprehensive cancer prevention in PLWH should also include ART adherence, vaccination against oncogenic viruses, treatment of hepatitis viruses and smoking cessation. Cancer screening for PLWH warrants further research on safety and efficacy as well as targeted efforts to increase adherence.

show abstract

Section: Site-specific Screening Approachmentioning

confidence: 99%

Screening for Cancer in Persons Living with HIV Infection

et al. 2016

View full text Add to dashboard Cite

show abstract

“…In the context of HIV, early diagnosis of infection and immunosuppression, along with access to medical care and antiretroviral therapy, plays an important role in HIV-related oral disease prevention. 29 Vaccination for HIV-related IDs is also a consideration in patients with HIV to prevent specific OIs. 30 This case also shows that not just rare pathogens but common organisms, such as Candida spp, can be opportunistic or more virulent in immunocompromised patients.…”

Section: Discussionmentioning

confidence: 99%

Opportunistic Oral Infections

Sedghizadeh

Mahabady

Allen

2017

Dental Clinics of North America

View full text Add to dashboard Cite

An opportunistic infection (OI) is a disease of microbial cause or pathogenesis generally thought to occur in hosts with weakened immunity. Oral OIs are associated with many risk factors and pathogens. Causative organisms for oral OIs have unique modes of transmission. The clinical presentation of oral OIs is heterogeneous and diagnosis can be challenging. Therefore, laboratory identification of causative pathogens is useful for definitive diagnosis and targeted therapeutics, and can be achieved by biological, serologic, histologic, and/or molecular methods. Clinical risk assessment and history with review of systems, and accurate diagnosis, treatment, and follow-up, are essential.

show abstract

“…A recent review on prevention of oral manifestations in HIV‐infected patients addressed the strategies to be implemented to prevent new‐onset and recurrent oral manifestations. The review observed that prevention of oral opportunistic conditions in HIV‐infected patients is primarily dependent on HAART being made available to these patients, since this treatment leads to restoration of the immune system by reducing viral load and increasing CD4 counts …”

Section: Management Protocolsmentioning

confidence: 99%

Common oral opportunistic infections in Human Immunodeficiency Virus infection/Acquired Immunodeficiency Syndrome: Changing epidemiology; diagnostic criteria and methods; management protocols

Ranganathan

Umadevi

2019

Periodontology 2000

View full text Add to dashboard Cite

There were 36.9 million in the world living with human immunodeficiency virus (HIV) infection/acquired immunodeficiency syndrome (AIDS) as of 2017, and new infections have seen a reduction by 18% since 2010. But this rate of decline is not sufficient for the goal of eradication of AIDS by 2030. Only 21.7 million people infected with HIV have accesses to antiretroviral therapy, with the rest at risk of the potential complications of HIV infection. It has been shown that oral lesions are diagnostic and prognostic of HIV infection, and many oral opportunistic infections continue to be a major problem, particularly in developing countries. It is therefore important that dental surgeons be aware and updated to recognize and manage the oral effects of HIV infection/AIDS. This chapter describes the classification, diagnosis, and management of oral lesions in these patients, based on our current understanding of the infection. This review also discusses the standardization of diagnosis of oral lesions in HIV infection/AIDS patients, immune reconstitution inflammatory syndrome case definition, and the research priorities formulated at the 7th World Workshop on Oral Health and Disease in AIDS.

show abstract

Current strategies for prevention of oral manifestations of human immunodeficiency virus

Cited by 25 publications

References 63 publications

Screening for Cancer in Persons Living with HIV Infection

Screening for Cancer in Persons Living with HIV Infection

Opportunistic Oral Infections

Common oral opportunistic infections in Human Immunodeficiency Virus infection/Acquired Immunodeficiency Syndrome: Changing epidemiology; diagnostic criteria and methods; management protocols

Contact Info

Product

Resources

About